Patients with severe illness may experience dyspnea and hypoxemia following the onset of the disease, which can rapidly progress to acute respiratory distress syndrome (41.8%), a predominant cause of hospitalization and mortality [3,4,5]
By improving blood sugar control, Semaglutide helps prevent the damage that can lead to heart problems
To address these gaps, researchers conducted a randomized, controlled, crossover, single-blind, free-living intervention trial in both apparently healthy adults and adults at moderate risk for developing CVD 1
These medications, which function by slowing gastric emptying, can lead to severe, chronic digestive issues, including persistent nausea, vomiting, abdominal distention, and the need for intensive medical interventions like IV therapy or feeding tubes